Small Molecule Innovator CDMO Market

Future Market Insights

Key Insight

The small molecule innovator CDMO market is projected to grow from USD 54.4 billion in 2025 to USD 101.2 billion by 2035, at a CAGR of 6.4%. Small Molecule API will dominate with a 57.3% market share, while preclinical will lead the stage type outlook segment with a 34.7% share.

September 10, 2025

Anurag Sharma

333 Pages

Cite this Report

Small Molecule Innovator CDMO Market

https://www.futuremarketinsights.com/reports/small-molecule-innovator-cdmo-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Asia Pacific
Cambrex Corporation
Catalent Inc
China
Thermo Fisher Scientific Inc.
Jubilant Life Sciences Ltd
Lonza Group
Piramal Pharma Solutions
Recipharm AB
Siegfried Holding AG
Sterling Pharma Solutions

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Small Molecule Innovator CDMO Market

Key Players

Similar Industry Reports